• Info
  • Insider Ownership

Insider Trading & Ownership of Richard A. Heyman

Location
Del Mar, CA
Summary
The estimated net worth of Richard A. Heyman is at least $5,607,828 dollars as of 22 Jan 2026. Richard A. Heyman is the Director of Oric Pharmaceuticals, Inc. and owns shares of Oric Pharmaceuticals, Inc. (ORIC) stock worth about $3.06M. Richard A. Heyman is the Director of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $2.55M.
Signature
/s/ Ben Hohl, by power of attorney
All Insider Reports
All Insider Reports

Notify me when Richard A. Heyman files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Richard A. Heyman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ORIC Oric Pharmaceuticals, Inc. Director $3,059,636 -$80,431 -2.6% 16 Jan 2026
ELVN Enliven Therapeutics, Inc. Director $2,548,192 -$381,182 -13% 20 Jan 2026
RYZB RayzeBio, Inc. Director $0 26 Feb 2024
GRTS Gritstone bio, Inc. Director 17 Jun 2022
MTCR Metacrine, Inc. Director 18 May 2022
PMVP PMV Pharmaceuticals, Inc. Director 05 Jun 2025
KA YUMANITY THERAPEUTICS, INC. Director 02 Jun 2021

Insider Transactions Reported by Richard A. Heyman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.